PURA VIDA INVESTMENTS, LLC - PUMA BIOTECHNOLOGY INC ownership

PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 178 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.

Quarter-by-quarter ownership
PURA VIDA INVESTMENTS, LLC ownership history of PUMA BIOTECHNOLOGY INC
ValueSharesWeighting
Q1 2020$540,000
-24.8%
64,000
+245.9%
0.06%
-37.3%
Q1 2019$718,000
-27.4%
18,500
+85.0%
0.10%
-75.4%
Q4 2017$989,000
-67.0%
10,000
-60.0%
0.41%
-52.7%
Q3 2017$2,994,000
-9.1%
25,000
-49.1%
0.88%
-12.4%
Q3 2016$3,294,00049,1251.00%
Other shareholders
PUMA BIOTECHNOLOGY INC shareholders Q1 2018
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 200,000$20,706,0006.01%
Redmile Group, LLC 230,673$23,882,0002.95%
WEATHERBIE CAPITAL, LLC 241,419$24,994,0002.31%
Tekla Capital Management LLC 185,820$19,238,0002.02%
Ghost Tree Capital, LLC 25,000$2,588,0001.59%
ADAGE CAPITAL PARTNERS GP, L.L.C. 5,686,668$588,741,0001.56%
Iguana Healthcare Management, LLC 25,000$2,588,0001.48%
Eventide Asset Management 42,100$4,359,0001.34%
Bain Capital Public Equity Management, LLC 401,330$41,550,0001.17%
Rock Springs Capital Management LP 31,500$3,261,0001.16%
View complete list of PUMA BIOTECHNOLOGY INC shareholders